Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology

Overview of attention for article published in BMC Cancer, August 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

DETECTION OF KIT POLYMORPHISM FOR PREDICTING THE RESPONSE TO CHECKPOINT BLOCKADE CANCER…

Application WO-2018146128-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.